Convergent Therapeutics

Drug DiscoveryWebsite

Operator of a clinical-stage biotechnology company intended to explore the full potential of alpha-emitting radioantibodies to treat cancer. The company offers a proprietary platform that links humani...

Drug Discovery
Healthcare
Cambridge, MA, United States
Founded 2020
10 employees
Website
Valuation
$280M
Market implied
Share Price
N/A
Total Raised
$130M
Last Round
Early Stage VC (Series A)
May 2023
Latest Funding Round
Early Stage VC (Series A)
May 1, 2023
$90M
raised
View all funding rounds
Investors
+4 other investors
View all 4 investors
Valuation History
1 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Convergent Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required